RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities - PubMed (original) (raw)
RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities
J B McCarthy et al. J Cell Biol. 1990 Mar.
Abstract
Cell adhesion to extracellular matrix components such as fibronectin has a complex basis, involving multiple determinants on the molecule that react with discrete cell surface macromolecules. Our previous results have demonstrated that normal and transformed cells adhere and spread on a 33-kD heparin binding fragment that originates from the carboxy-terminal end of particular isoforms (A-chains) of human fibronectin. This fragment promotes melanoma adhesion and spreading in an arginyl-glycyl-aspartyl-serine (RGDS) independent manner, suggesting that cell adhesion to this region of fibronectin is independent of the typical RGD/integrin-mediated binding. Two synthetic peptides from this region of fibronectin were recently identified that bound [3H]heparin in a solid-phase assay and promoted the adhesion and spreading of melanoma cells (McCarthy, J. B., M. K. Chelberg, D. J. Mickelson, and L. T. Furcht. 1988. Biochemistry. 27:1380-1388). The current studies further define the cell adhesion and heparin binding properties of one of these synthetic peptides. This peptide, termed peptide I, has the sequence YEKPGSP-PREVVPRPRPGV and represents residues 1906-1924 of human plasma fibronectin. In addition to promoting RGD-independent melanoma adhesion and spreading in a concentration-dependent manner, this peptide significantly inhibited cell adhesion to the 33-kD fragment or intact fibronectin. Polyclonal antibodies generated against peptide I also significantly inhibited cell adhesion to the peptide, to the 33-kD fragment, but had minimal effect on melanoma adhesion to fibronectin. Anti-peptide I antibodies also partially inhibited [3H]heparin binding to fibronectin, suggesting that peptide I represents a major heparin binding domain on the intact molecule. The cell adhesion activity of another peptide from the 33-kD fragment, termed CS1 (Humphries, M. J., A. Komoriya, S. K. Akiyama, K. Olden, and K. M. Yamada. 1987. J. Biol. Chem., 262:6886-6892) was contrasted with peptide I. Whereas both peptides promoted RGD-independent cell adhesion, peptide CS1 failed to bind heparin, and exogenous peptide CS1 failed to inhibit peptide I-mediated cell adhesion. The results demonstrate a role for distinct heparin-dependent and -independent cell adhesion determinants on the 33-kD fragment, neither of which are related to the RGD-dependent integrin interaction with fibronectin.
Similar articles
- Recognition of the A chain carboxy-terminal heparin binding region of fibronectin involves multiple sites: two contiguous sequences act independently to promote neural cell adhesion.
Haugen PK, McCarthy JB, Skubitz AP, Furcht LT, Letourneau PC. Haugen PK, et al. J Cell Biol. 1990 Dec;111(6 Pt 1):2733-45. doi: 10.1083/jcb.111.6.2733. J Cell Biol. 1990. PMID: 2277084 Free PMC article. - Coordinate role for cell surface chondroitin sulfate proteoglycan and alpha 4 beta 1 integrin in mediating melanoma cell adhesion to fibronectin.
Iida J, Skubitz AP, Furcht LT, Wayner EA, McCarthy JB. Iida J, et al. J Cell Biol. 1992 Jul;118(2):431-44. doi: 10.1083/jcb.118.2.431. J Cell Biol. 1992. PMID: 1629241 Free PMC article. - Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities.
McCarthy JB, Chelberg MK, Mickelson DJ, Furcht LT. McCarthy JB, et al. Biochemistry. 1988 Feb 23;27(4):1380-8. doi: 10.1021/bi00404a044. Biochemistry. 1988. PMID: 2966638 - The cell interaction sites of fibronectin in tumour metastasis.
Humphries MJ, Yasuda Y, Olden K, Yamada KM. Humphries MJ, et al. Ciba Found Symp. 1988;141:75-93. doi: 10.1002/9780470513736.ch5. Ciba Found Symp. 1988. PMID: 2855415 Review. - Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif.
D'Souza SE, Ginsberg MH, Plow EF. D'Souza SE, et al. Trends Biochem Sci. 1991 Jul;16(7):246-50. doi: 10.1016/0968-0004(91)90096-e. Trends Biochem Sci. 1991. PMID: 1926332 Review.
Cited by
- Dendritic Scaffold onto Titanium Implants. A Versatile Strategy Increasing Biocompatibility.
Molina N, González A, Monopoli D, Mentado B, Becerra J, Santos-Ruiz L, Vida Y, Perez-Inestrosa E. Molina N, et al. Polymers (Basel). 2020 Apr 1;12(4):770. doi: 10.3390/polym12040770. Polymers (Basel). 2020. PMID: 32244665 Free PMC article. - Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.
Billings PC, Pacifici M. Billings PC, et al. Connect Tissue Res. 2015;56(4):272-80. doi: 10.3109/03008207.2015.1045066. Connect Tissue Res. 2015. PMID: 26076122 Free PMC article. Review. - In situ modulation of cell behavior via smart dual-ligand surfaces.
Pulsipher A, Park S, Dutta D, Luo W, Yousaf MN. Pulsipher A, et al. Langmuir. 2014 Nov 18;30(45):13656-66. doi: 10.1021/la503521x. Epub 2014 Nov 6. Langmuir. 2014. PMID: 25373713 Free PMC article. - Bioactive coatings for orthopaedic implants-recent trends in development of implant coatings.
Zhang BG, Myers DE, Wallace GG, Brandt M, Choong PF. Zhang BG, et al. Int J Mol Sci. 2014 Jul 4;15(7):11878-921. doi: 10.3390/ijms150711878. Int J Mol Sci. 2014. PMID: 25000263 Free PMC article. Review. - Spontaneous phosphoinositide 3-kinase signaling dynamics drive spreading and random migration of fibroblasts.
Weiger MC, Wang CC, Krajcovic M, Melvin AT, Rhoden JJ, Haugh JM. Weiger MC, et al. J Cell Sci. 2009 Feb 1;122(Pt 3):313-23. doi: 10.1242/jcs.037564. Epub 2009 Jan 6. J Cell Sci. 2009. PMID: 19126672 Free PMC article.
References
- EMBO J. 1985 Jul;4(7):1755-9 - PubMed
- Cancer Metastasis Rev. 1985;4(2):125-52 - PubMed
- EMBO J. 1985 Oct;4(10):2519-24 - PubMed
- J Cell Biol. 1986 Jan;102(1):179-88 - PubMed
- EMBO J. 1986 Apr;5(4):665-70 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous